What changed 10-Q

Item 5. Other Information

2026-08-06 compared with 2026-05-07 · 4 added, 0 removed, 29 unchanged (12% of the section changed)

7 unchanged sentences

(incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on October 27, 2023).

10.1* Ginkgo Bioworks Holdings, Inc.

Amended and Restated Non-Employee Director Compensation Program

31.1* Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

15 unchanged sentences

Ginkgo Bioworks Holdings, Inc.

August 6, 2026

/s/ Jason Kelly

Chief Executive Officer (Principal Executive Officer)

August 6, 2026

/s/ Steven Coen

1 unchanged sentence

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.